Targeted Alpha Therapy with 213Bi

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|4|4|295-305

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.4, Iss.4, 2011-10, pp. : 295-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 154-155

Bentham Science Publishers

Access to resources Recommend Favorite

Future Prospects for Targeted Alpha Therapy

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 336-342

Bentham Science Publishers

Access to resources Recommend Favorite

Production of Alpha Emitters for Targeted Alpha Therapy

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 135-143

Bentham Science Publishers

Access to resources Recommend Favorite

New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 240-250

Bentham Science Publishers

Access to resources Recommend Favorite